Schedule 13G ownership disclosure
Amylyx Pharmaceuticals Inc
Security class unavailable · CUSIP: 03237H101
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,358,492
- Percent of class
- 6.5800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-015304
- Form type
- SC 13G
- Filer
- Amylyx Pharmaceuticals, Inc.
- CIK
- CIK 1658551
- Filed
- Feb 09, 2023
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership